Associate Professor Ben Lacey
Contact information
Colleges
Ben Lacey
MBChB MSc DPhil FFPH
UK BIOBANK
Ben Lacey is Associate Professor of Medicine and Epidemiology at UK Biobank, Oxford Population Health, University of Oxford.
His work seeks to further understanding of the burden of disease and major risk factors in populations, mainly through the design, conduct and analysis of large-scale cohort studies. He has worked on cohorts in the UK, India, Cuba and elsewhere.
He studied Medicine at the University of Edinburgh, qualifying in 2004. After a few years clinical work, he undertook specialty training in Public Health Medicine, and received an MSc in Global Health Science and a DPhil in Epidemiology from the University of Oxford. He joined Oxford Population Health in 2015.
He is also an Honorary Consultant Physician in Public Health at Oxford University Hospitals NHS Trust, and Associate Fellow of Green Templeton College, Oxford.
Recent publications
-
Corrigendum to "Waist-to-height ratio and body fat percentage as risk factors for ischemic cardiovascular disease: a prospective cohort study from UK Biobank" [Am J Clin Nutr 119 (2024) 1386-1396].
Journal article
Feng Q. et al, (2024), Am J Clin Nutr
-
Adiposity, fat-free mass and incident heart failure in 500 000 individuals.
Journal article
Oguntade AS. et al, (2024), Open Heart, 11
-
Comparison of body composition measures assessed by bioelectrical impedance analysis versus dual-energy X-ray absorptiometry in the United Kingdom Biobank
Journal article
Feng Q. et al, (2024), Clinical Nutrition ESPEN
-
Waist-to-height ratio and body fat percentage as risk factors for ischemic cardiovascular disease: a prospective cohort study from UK Biobank.
Journal article
Feng Q. et al, (2024), Am J Clin Nutr, 119, 1386 - 1396
-
The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019
Journal article
Santos JV. et al, (2024), BMC Public Health, 24
-
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
Journal article
GBD 2021 Forecasting Collaborators None., (2024), Lancet, 403, 2204 - 2256